– UK, London – Legal & General Group Plc (LON: LGEN) today announced the appointment of Carolyn Johnson to its Board as an independent non-executive director, with immediate effect.
“I am delighted to welcome Carolyn to the Group Board. Carolyn brings with her a wealth of experience in insurance and in financial services more generally. Her appointment will strengthen the Board’s engagement with our successful and growing US businesses in life insurance, asset management and pension risk transfer. I very much look forward to working with her.” said Board Chairman, Sir John Kingman.
Carolyn Johnson will also join the Audit, Group Risk and Group Nominations, and Corporate Governance Committees.
About Carolyn Johnson
Carolyn Johnson has extensive knowledge of the insurance and financial services industries following a 30-year executive career in the United States. In particular, she has deep experience in the life insurance market, having held senior roles at AIG, Voya Financial and Protective Life Corporation.
Carolyn Johnson was a director of Majesco, Inc until 2020.
About Legal & General Group Plc
Established in 1836, Legal & General is one of the UK’s leading financial services groups and a major global investor, with over £1.4 trillion in total assets under management of which a third is international. L&G also provides powerful asset origination capabilities. Together, these underpin our leading retirement and protection solutions: we are a leading international player in pension risk transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. As at 16 June 2022, Legal & General has a market capitalisation of £14.6 billion.
For more information: https://www.legalandgeneral.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
